ADC Therapeutics SA

NYSE: ADCT · Real-Time Price · USD
3.46
0.12 (3.59%)
At close: Jun 05, 2025, 3:59 PM
3.60
4.05%
Pre-market: Jun 06, 2025, 04:13 AM EDT

ADC Therapeutics SA Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023
Product Revenue 69.28M 69.06M
Product Revenue Growth +0.32% n/a
Royalty Revenue Revenue 1.56M 498K
Royalty Revenue Revenue Growth +212.65% n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023
Emea Revenue 1.56M 498K
Emea Revenue Growth +212.65% n/a
United States Revenue 69.28M 69.06M
United States Revenue Growth +0.32% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue -598K 20.87M 20.68M 20.1M 22.58M 25.22M 23.09M 12.6M 30.49M 31.31M 36.46M 35.9M 37.38M 36.53M 33.63M 34.59M 31.49M 29.45M 20.27M 19M 8.51M 4.92M 2.3M 4.09M 3.3M 2.4M 2.4M 1.98M 1.98M
Selling, General, and Administrative Revenue Growth -102.86% +0.96% +2.86% -10.97% -10.48% +9.23% +83.28% -58.68% -2.62% -14.12% +1.57% -3.96% +2.33% +8.61% -2.76% +9.83% +6.94% +45.26% +6.71% +123.25% +72.97% +113.73% -43.70% +24.06% +37.36% 0.00% +20.91% 0.00% n/a
Research and Development Revenue 28.93M 27.1M 32.5M 24.3M 25.73M 30.33M 28.44M 31.94M 39.48M 48.73M 41.68M 48.54M 48.95M 42.49M 36.8M 39.53M 39.17M 48.55M 32.16M 25.95M 35.38M 30.42M 30.54M 21.76M 23.29M 29.09M 29.09M 30.07M 30.07M
Research and Development Revenue Growth +6.74% -16.62% +33.78% -5.60% -15.15% +6.65% -10.97% -19.09% -18.99% +16.93% -14.14% -0.85% +15.20% +15.45% -6.90% +0.92% -19.32% +50.99% +23.91% -26.64% +16.27% -0.38% +40.35% -6.55% -19.95% 0.00% -3.25% 0.00% n/a